Clinical trial
Systems Biology to Identify Biomarkers of Neonatal Vaccine Immunogenicity
NCT03246230 is registered in ClinicalTrials.gov with Boston Children's Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Systems Biology to Identify Biomarkers of Neonatal Vaccine Immunogenicity
- Lead sponsor
- Boston Children's Hospital
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- September 6, 2017
- Completion date
- August 29, 2022
- Enrollment
- 911 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
newborn vaccine immunogenicity